Loading
Latest filing published 21 Sept 2020 for WAVERLEY PHARMA INC., €1,188.
No signal scores available.
Haaris Uddin discloses dealings in Waverley Pharma Inc. to SEDI. We count 3 filings; the first trade dates from 8 January 2020 and the latest from 21 September 2020.
The open-market record is one-sided, with 2 purchases worth €2,214 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 21 September 2020 came the latest disclosure, an open-market purchase for €1,188 in Waverley Pharma Inc. Filings reach the SEDI feed a median of 3 days after the trade. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations